2017
DOI: 10.7717/peerj.3283
|View full text |Cite
|
Sign up to set email alerts
|

Screening of a natural compound library identifies emodin, a natural compound from Rheum palmatum Linn that inhibits DPP4

Abstract: Historically, Chinese herbal medicines have been widely used in the treatment of hyperglycemia, but the mechanisms underlying their effectiveness remain largely unknown. Here, we screened a compound library primarily comprised of natural compounds extracted from herbs and marine organisms. The results showed that emodin, a natural compound from Rheum palmatum Linn, inhibited DPP4 activity with an in vitro IC 50 of 5.76 µM without inhibiting either DPP8 or DPP9. A docking model revealed that emodin binds to DPP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 35 publications
(43 reference statements)
0
11
0
Order By: Relevance
“…The authors further revealed that emodin binds to DPP‐4 protein with relatively low affinity at Glu205 and Glu206 positions. To confirm the in vitro data, oral administration of emodin (3–30 mg/kg/4 hr) reduced blood glucose level and plasma DPP‐4 activity and elevated glucagon‐like peptide‐1 activity in Balb/C and ob/ob (−/−) mice (Wang et al, ). Jang et al () have reported that emodin from S. tora L. inhibited aldose reductase activity and advanced glycation end products formation with IC 50 values of 15.9 and 118 μM, respectively.…”
Section: Resultsmentioning
confidence: 94%
See 3 more Smart Citations
“…The authors further revealed that emodin binds to DPP‐4 protein with relatively low affinity at Glu205 and Glu206 positions. To confirm the in vitro data, oral administration of emodin (3–30 mg/kg/4 hr) reduced blood glucose level and plasma DPP‐4 activity and elevated glucagon‐like peptide‐1 activity in Balb/C and ob/ob (−/−) mice (Wang et al, ). Jang et al () have reported that emodin from S. tora L. inhibited aldose reductase activity and advanced glycation end products formation with IC 50 values of 15.9 and 118 μM, respectively.…”
Section: Resultsmentioning
confidence: 94%
“…Emodin isolated from R. palmatum L. inhibited the activity of DPP‐4 with an IC 50 values of 5.76 μM (Wang et al, ). The authors further revealed that emodin binds to DPP‐4 protein with relatively low affinity at Glu205 and Glu206 positions.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Screening DPP-4 inhibitors for treating diabetes is a recently developing field (since 2006), when a study reported that DPP-4 might regulate insulin sensitivity via degradation of GLP-1 [22]. Up to now, few natural DPP-4 inhibitors have been reported [23] From plant origin, DPP-4 inhibitory activities of kaempferol and derivatives, linustatins, chrysin, stigmasterol, emodin, lupeol, mangiferin, vitisins, and soybean hydrolysates were all validated via direct enzymatic assay and in vivo hypoglycemic analysis [24,25,26,27,28,29,30,31]. Moreover, the methanolic extracts of Ficus benghalensis , Syzigium cumini , Ocimum sanctum , and Eucalyptus sp.…”
Section: Discussionmentioning
confidence: 99%